JP2002003453A - METHOD FOR PURIFYING OPTICALLY ACTIVE alpha-METHYL- BIS-3,5-(TRIFLUOROMETHYL) BENZYLAMINES - Google Patents

METHOD FOR PURIFYING OPTICALLY ACTIVE alpha-METHYL- BIS-3,5-(TRIFLUOROMETHYL) BENZYLAMINES

Info

Publication number
JP2002003453A
JP2002003453A JP2000185405A JP2000185405A JP2002003453A JP 2002003453 A JP2002003453 A JP 2002003453A JP 2000185405 A JP2000185405 A JP 2000185405A JP 2000185405 A JP2000185405 A JP 2000185405A JP 2002003453 A JP2002003453 A JP 2002003453A
Authority
JP
Japan
Prior art keywords
acid
optically active
trifluoromethyl
methyl
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000185405A
Other languages
Japanese (ja)
Other versions
JP3902384B2 (en
Inventor
Akihisa Ishii
章央 石井
Katsu Kuriyama
克 栗山
Manabu Yasumoto
学 安本
Masatomi Kanai
正富 金井
Takashi Hayamizu
崇 速水
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Central Glass Co Ltd
Original Assignee
Central Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central Glass Co Ltd filed Critical Central Glass Co Ltd
Priority to JP2000185405A priority Critical patent/JP3902384B2/en
Priority to US09/853,085 priority patent/US6797842B2/en
Publication of JP2002003453A publication Critical patent/JP2002003453A/en
Application granted granted Critical
Publication of JP3902384B2 publication Critical patent/JP3902384B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method for industrially readily and efficiently purifying optically active α-methyl-bis-3,5-(trifluoromethyl)benzylamine of an important intermediate for a medicine and an agrochemical, in high optical purity. SOLUTION: The optically active α-methyl-bis-3,5-(trifluoromethyl) benzylamines are purified so as to have a high optical purity by forming the α-methyl-bis-3,5-(trifluoromethyl)benzylamines into a salt of an organic acid, and recrystallizing the resultant salt.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、医薬および農薬の
重要中間体である光学活性α−メチル−ビス−3,5−
(トリフルオロメチル)ベンジルアミンを高い光学純度
で得るための精製方法に関する。
TECHNICAL FIELD The present invention relates to an optically active α-methyl-bis-3,5-, an important intermediate of pharmaceuticals and agricultural chemicals.
The present invention relates to a purification method for obtaining (trifluoromethyl) benzylamine with high optical purity.

【0002】[0002]

【従来の技術】光学活性α−メチル−ビス−3,5−
(トリフルオロメチル)ベンジルアミンは、医薬および
農薬の重要中間体である。該光学活性アミンの製造方法
に関しては、J. Am. Chem. Soc., 112, 5741(1990)に1
件報告されているのみで、J. Chem. Soc., Perkin Tran
s. 1, 2039(1985)記載のオキシム誘導体の不斉還元を参
考にして合成している。しかしながら、その光学純度は
71%ee(S)と中程度で、化学収率も15%と低
く、該光学活性アミンを高い光学純度で得るための工業
的に簡便で且つ効率の良い製造方法ではなかった。
2. Description of the Related Art Optically active α-methyl-bis-3,5-
(Trifluoromethyl) benzylamine is a key intermediate in medicine and pesticides. The method for producing the optically active amine is described in J. Am. Chem. Soc., 112, 5741 (1990).
J. Chem. Soc., Perkin Tran
s. 1, 2039 (1985) with reference to the asymmetric reduction of an oxime derivative. However, its optical purity is moderate at 71% ee (S), and its chemical yield is as low as 15%. An industrially simple and efficient production method for obtaining the optically active amine with high optical purity is not available. Did not.

【0003】[0003]

【発明が解決しようとする課題】本発明の目的は、光学
活性α−メチル−ビス−3,5−(トリフルオロメチ
ル)ベンジルアミン自体、または、その合成中間体を無
機酸または有機酸の塩にして再結晶精製することによ
り、高い光学純度のα−メチル−ビス−3,5−(トリ
フルオロメチル)ベンジルアミンを得ることである。
SUMMARY OF THE INVENTION An object of the present invention is to provide an optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamine itself or a synthetic intermediate thereof as a salt of an inorganic acid or an organic acid. To obtain α-methyl-bis-3,5- (trifluoromethyl) benzylamine of high optical purity.

【0004】[0004]

【課題を解決するための手段】本発明者等は、上記の課
題を解決すべく鋭意検討を行った結果、光学活性α−メ
チル−ビス−3,5−(トリフルオロメチル)ベンジル
アミン自体、または、その合成中間体を無機酸または有
機酸の塩にして再結晶精製することにより、高い光学純
度のα−メチル−ビス−3,5−(トリフルオロメチ
ル)ベンジルアミンが得られることを明らかにした。
Means for Solving the Problems The present inventors have made intensive studies to solve the above-mentioned problems, and as a result, have found that optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamine itself, Alternatively, it is apparent that α-methyl-bis-3,5- (trifluoromethyl) benzylamine having a high optical purity can be obtained by recrystallizing and purifying the synthetic intermediate with a salt of an inorganic acid or an organic acid. I made it.

【0005】すなわち、本発明は、一般式[1]That is, the present invention provides a compound represented by the general formula [1]:

【0006】[0006]

【化3】 Embedded image

【0007】[式中、Rは、水素、ベンジル基、アリル
基またはC*HMeArで示される光学活性α−アリー
ルエチル基を表し、Arは、フェニル基または1もしく
は2−ナフチル基を表し、*は、不斉炭素を表す]で示
される光学活性α−メチル−ビス−3,5−(トリフル
オロメチル)ベンジルアミン類を無機酸または有機酸の
塩にして再結晶精製することを特徴とする精製方法であ
る。
[Wherein, R represents hydrogen, a benzyl group, an allyl group, or an optically active α-arylethyl group represented by C * HMeAr, Ar represents a phenyl group or 1 or 2-naphthyl group, Represents an asymmetric carbon.] An optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamine represented by the following formula is converted into a salt of an inorganic acid or an organic acid and purified by recrystallization. It is a purification method.

【0008】また、本発明は、一般式[1]Further, the present invention provides a compound represented by the general formula [1]:

【0009】[0009]

【化4】 Embedded image

【0010】[式中、Rは、水素、ベンジル基、アリル
基またはC*HMeArで示される光学活性α−アリー
ルエチル基を表し、Arは、フェニル基または1もしく
は2−ナフチル基を表し、*は、不斉炭素を表す]で示
される光学活性α−メチル−ビス−3,5−(トリフル
オロメチル)ベンジルアミン類の無機酸または有機酸の
塩である。
Wherein R represents hydrogen, a benzyl group, an allyl group or an optically active α-arylethyl group represented by C * HMeAr; Ar represents a phenyl group or 1 or 2-naphthyl group; Represents an asymmetric carbon atom], and is a salt of an optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamine with an inorganic or organic acid.

【0011】[0011]

【発明の実施の形態】以下、本発明の光学活性α−メチ
ル−ビス−3,5−(トリフルオロメチル)ベンジルア
ミン類の精製方法について詳細に説明する。
BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, a method for purifying optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamine of the present invention will be described in detail.

【0012】本発明の一般式[1]で示される光学活性
α−メチル−ビス−3,5−(トリフルオロメチル)ベ
ンジルアミン類としては、どのような方法で製造された
ものでもよく、下式に示す6化合物を挙げることができ
る。その中でも、α−メチル−ビス−3,5−(トリフ
ルオロメチル)ベンジルアミン自体(1−a)、N−ベ
ンジル体(1−b)、N−α−フェニルエチル体(1−
d)がより好ましい。*は、不斉炭素を表し、1−a、
1−bおよび1−cの立体化学にはR体またはS体があ
り、その光学純度が10%ee以上のものを用いること
ができる。また、1−d、1−eおよび1−fの立体化
学にはR−R体、S−R体、R−S体またはS−S体の
組み合わせがあり(ハイフンの前に示した絶対配置は、
α−メチル−ビス−3,5−(トリフルオロメチル)ベ
ンジル基側の絶対配置を表し、ハイフンの後に示した絶
対配置は、キラル補助剤であるα−アリールエチル基側
の絶対配置を表し、通常、98%ee以上のR体または
S体のキラル補助剤を用いる)、そのジアステレオマー
過剰率が10%de以上のものを用いることができる。
The optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamine represented by the general formula [1] of the present invention may be produced by any method. Six compounds represented by the formula can be given. Among them, α-methyl-bis-3,5- (trifluoromethyl) benzylamine itself (1-a), N-benzyl form (1-b), N-α-phenylethyl form (1-
d) is more preferred. * Represents an asymmetric carbon, 1-a,
The stereochemistry of 1-b and 1-c includes R-form and S-form, and those having an optical purity of 10% ee or more can be used. The stereochemistry of 1-d, 1-e, and 1-f includes combinations of RR, SR, RS, and SS (the absolute configuration shown before the hyphen). Is
represents the absolute configuration on the α-methyl-bis-3,5- (trifluoromethyl) benzyl group side, and the absolute configuration shown after the hyphen represents the absolute configuration on the α-arylethyl group side as a chiral auxiliary, Usually, an R-form or S-form chiral auxiliary having 98% ee or more is used), and those having a diastereomer excess of 10% de or more can be used.

【0013】[0013]

【化5】 Embedded image

【0014】本発明で用いられる無機酸としては、炭
酸、塩酸、硫酸、硝酸、臭化水素酸、沃化水素酸、リン
酸、ホウ酸、過塩素酸等を挙げることができる。その中
でも、塩酸がより好ましい。
Examples of the inorganic acid used in the present invention include carbonic acid, hydrochloric acid, sulfuric acid, nitric acid, hydrobromic acid, hydroiodic acid, phosphoric acid, boric acid, perchloric acid and the like. Among them, hydrochloric acid is more preferred.

【0015】本発明で用いられる有機酸としては、酢
酸、プロピオン酸、酪酸、イソ酪酸、吉草酸、イソ吉草
酸、ヘキサン酸、ヘプタン酸、シクロヘキサンカルボン
酸、オクタン酸、フェニル酢酸、3−フェニルプロピオ
ン酸等のアルキルカルボン酸類、クロロ酢酸、ジクロロ
酢酸、トリクロロ酢酸、フルオロ酢酸、ジフルオロ酢
酸、トリフルオロ酢酸、ブロモ酢酸、ヨード酢酸、2−
クロロプロピオン酸、3−クロロプロピオン酸等のハロ
アルキルカルボン酸類、アクリル酸、クロトン酸、シト
ラコン酸、マレイン酸、フマル酸、cisまたはtra
ns−ケイ皮酸等の不飽和カルボン酸類、安息香酸、
o,mまたはp−トルイル酸、o,mまたはp−フルオ
ロ安息香酸、o,mまたはp−クロロ安息香酸、o,m
またはp−ブロモ安息香酸、o,mまたはp−ヨード安
息香酸、o,mまたはp−ヒドロキシ安息香酸、o,m
またはp−アニス酸、o,mまたはp−アミノ安息香
酸、o,mまたはp−ニトロ安息香酸、o,mまたはp
−シアノ安息香酸、o,mまたはp−ベンゼンジカルボ
ン酸、α,βまたはγ−ピコリン酸、2,6−ピリジン
ジカルボン酸、1または2−ナフトエ酸等の芳香族カル
ボン酸類、メタンスルホン酸、クロロメタンスルホン
酸、トリフルオロメタンスルホン酸、ベンゼンスルホン
酸、p−トルエンスルホン酸、p−フェノールスルホン
酸等のスルホン酸類、乳酸、リンゴ酸、酒石酸、ジベン
ゾイル酒石酸、2−フェニルプロピオン酸、マンデル
酸、カンファー酸、シス−2−ベンズアミドシクロヘキ
サンカルボン酸等の光学活性カルボン酸類、フェニルエ
タンスルホン酸、10−カンファースルホン酸等の光学
活性スルホン酸類、2,2’−(1,1’−ビナフチ
ル)リン酸等の光学活性リン酸類、4−アミノ酪酸、フ
ェニルグリシン、アスパラギン酸等の光学活性アミノ酸
類、ピログルタミン酸、N−アセチル−3,5−ジブロ
モ−チロシン、N−アシル−フェニルアラニン、N−ア
シル−アスパラギン酸、N−アシルグルタミン酸、N−
アシルプロリン等の光学活性N−アシルアミノ酸類(N
−アシル基としては、アセチル基、ベンジルオキシカル
ボニル基、ベンゾイル基、ベンゼンスルホニル基、p−
トルエンスルホニル基等を表す)、その他の有機酸とし
ては、ギ酸、シュウ酸、マロン酸、コハク酸、アジピン
酸、ピメリン酸、シアノ酢酸、クエン酸、グリコール
酸、グリオキシル酸、ピルビン酸、レブリン酸、オキサ
ロ酢酸、メルカプト酢酸、フェノキシ酢酸、ピクリン酸
等を挙げることができる。光学活性カルボン酸類、光学
活性スルホン酸類、光学活性リン酸類、光学活性アミノ
酸類または光学活性N−アシルアミノ酸類には、光学異
性体が存在するが、両方の光学異性体を用いることがで
きる。その中でも、p−トルエンスルホン酸、光学活性
酒石酸、光学活性マンデル酸がより好ましい。
The organic acids used in the present invention include acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, hexanoic acid, heptanoic acid, cyclohexanecarboxylic acid, octanoic acid, phenylacetic acid, and 3-phenylpropionic acid. Alkyl carboxylic acids such as acids, chloroacetic acid, dichloroacetic acid, trichloroacetic acid, fluoroacetic acid, difluoroacetic acid, trifluoroacetic acid, bromoacetic acid, iodoacetic acid, 2-
Haloalkylcarboxylic acids such as chloropropionic acid and 3-chloropropionic acid, acrylic acid, crotonic acid, citraconic acid, maleic acid, fumaric acid, cis or tra
unsaturated carboxylic acids such as ns-cinnamic acid, benzoic acid,
o, m or p-toluic acid, o, m or p-fluorobenzoic acid, o, m or p-chlorobenzoic acid, o, m
Or p-bromobenzoic acid, o, m or p-iodobenzoic acid, o, m or p-hydroxybenzoic acid, o, m
Or p-anisic acid, o, m or p-aminobenzoic acid, o, m or p-nitrobenzoic acid, o, m or p
-Aromatic carboxylic acids such as cyanobenzoic acid, o, m or p-benzenedicarboxylic acid, α, β or γ-picolinic acid, 2,6-pyridinedicarboxylic acid, 1 or 2-naphthoic acid, methanesulfonic acid, chloro Sulfonic acids such as methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, p-phenolsulfonic acid, lactic acid, malic acid, tartaric acid, dibenzoyltartaric acid, 2-phenylpropionic acid, mandelic acid, camphoric acid Optically active carboxylic acids such as cis-2-benzamidocyclohexanecarboxylic acid, optically active sulfonic acids such as phenylethanesulfonic acid and 10-camphorsulfonic acid, and 2,2 ′-(1,1′-binaphthyl) phosphoric acid Optically active phosphoric acids, 4-aminobutyric acid, phenylglycine, asparagine Optically active amino acid such as acid, pyroglutamic acid, N- acetyl-3,5-dibromo - tyrosine, N- acyl - Phenylalanine, N- acyl - aspartic acid, N- acyl glutamic acid, N-
Optically active N-acyl amino acids such as acylproline (N
-Acyl groups include acetyl, benzyloxycarbonyl, benzoyl, benzenesulfonyl, p-
Such as formic acid, oxalic acid, malonic acid, succinic acid, adipic acid, pimelic acid, cyanoacetic acid, citric acid, glycolic acid, glyoxylic acid, pyruvic acid, levulinic acid, and the like. Oxaloacetic acid, mercaptoacetic acid, phenoxyacetic acid, picric acid and the like can be mentioned. Optically active carboxylic acids, optically active sulfonic acids, optically active phosphoric acids, optically active amino acids and optically active N-acyl amino acids have optical isomers, and both optical isomers can be used. Among them, p-toluenesulfonic acid, optically active tartaric acid, and optically active mandelic acid are more preferable.

【0016】本発明で用いられる酸の使用量としては、
一般式[1]で示される光学活性α−メチル−ビス−
3,5−(トリフルオロメチル)ベンジルアミン類に対
して、0.3モル当量以上使用すればよく、0.3〜5
モル当量が好ましく、特に、0.3〜2モル当量がより
好ましい。
The amount of the acid used in the present invention is as follows:
Optically active α-methyl-bis- represented by the general formula [1]
It may be used in an amount of 0.3 molar equivalent or more based on 3,5- (trifluoromethyl) benzylamine,
Molar equivalents are preferred, especially 0.3 to 2 molar equivalents.

【0017】本発明の塩の調製方法は、光学活性α−メ
チル−ビス−3,5−(トリフルオロメチル)ベンジル
アミン類と酸の組み合わせにより適宜決めればよく、通
常、再結晶溶媒に該光学活性アミン類と酸を直接加え混
合することにより、または、それぞれの溶液を予め準備
し溶液同士を混合することにより調製することができ
る。
The method for preparing the salt of the present invention may be determined appropriately depending on the combination of the optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamines and the acid. It can be prepared by directly adding and mixing the active amines and the acid, or by preparing respective solutions in advance and mixing the solutions.

【0018】本発明で用いられる再結晶溶媒としては、
光学活性α−メチル−ビス−3,5−(トリフルオロメ
チル)ベンジルアミン類、酸またはその塩と反応しない
ものであれば、特に制限はなく、精製前の光学純度また
はジアステレオマー過剰率、または、目標とする精製後
の光学純度またはジアステレオマー過剰率および回収率
等により適宜決めればよい。かかる再結晶溶媒として
は、n−ペンタン、n−ヘキサン、c−ヘキサン、n−
ヘプタン等の脂肪族炭化水素系、ベンゼン、トルエン、
エチルベンゼン、キシレン、メシチレン等の芳香族炭化
水素系、塩化メチレン、クロロホルム、1,2−ジクロ
ロエタン等のハロゲン化炭化水素系、ジエチルエーテ
ル、テトラヒドロフラン、t−ブチルメチルエーテル、
1,4−ジオキサン等のエーテル系、アセトン、メチル
エチルケトン、メチルイソブチルケトン等のケトン系、
酢酸エチル、酢酸n−ブチル等のエステル系、アセトニ
トリル、プロピオニトリル等のニトリル系、メタノー
ル、エタノール、n−プロパノール、i−プロパノー
ル、n−ブタノール等のアルコール系、水等を挙げるこ
とができる。その中でも、n−ヘキサン、n−ヘプタ
ン、トルエン、塩化メチレン、t−ブチルメチルエーテ
ル、アセトン、酢酸エチル、アセトニトリル、メタノー
ル、エタノール、i−プロパノールがより好ましい。こ
れらの溶媒は単独または組み合わせて用いることができ
る。
The recrystallization solvent used in the present invention includes:
There is no particular limitation as long as it does not react with the optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamines, acids or salts thereof, and optical purity or diastereomeric excess before purification, Alternatively, it may be appropriately determined according to the target optical purity after purification, diastereomer excess ratio, recovery ratio, and the like. Such recrystallization solvents include n-pentane, n-hexane, c-hexane, and n-hexane.
Aliphatic hydrocarbons such as heptane, benzene, toluene,
Ethylbenzene, xylene, aromatic hydrocarbons such as mesitylene, methylene chloride, chloroform, halogenated hydrocarbons such as 1,2-dichloroethane, diethyl ether, tetrahydrofuran, t-butyl methyl ether,
Ethers such as 1,4-dioxane, ketones such as acetone, methyl ethyl ketone and methyl isobutyl ketone,
Examples include esters such as ethyl acetate and n-butyl acetate, nitriles such as acetonitrile and propionitrile, alcohols such as methanol, ethanol, n-propanol, i-propanol and n-butanol, and water. Among them, n-hexane, n-heptane, toluene, methylene chloride, t-butyl methyl ether, acetone, ethyl acetate, acetonitrile, methanol, ethanol, and i-propanol are more preferable. These solvents can be used alone or in combination.

【0019】本発明で用いられる再結晶溶媒の使用量と
しては、精製前の塩が、熱時、完全にまたは部分的に溶
解する範囲であれば、特に制限はなく、精製前の光学純
度またはジアステレオマー過剰率、または、目標とする
精製後の光学純度またはジアステレオマー過剰率および
回収率等により適宜決めればよい。通常、一般式[1]
で示される光学活性α−メチル−ビス−3,5−(トリ
フルオロメチル)ベンジルアミン類の塩に対して、1容
量以上使用すればよく、1〜100容量が好ましく、特
に、1〜50容量がより好ましい。
The amount of the recrystallization solvent used in the present invention is not particularly limited as long as the salt before purification is completely or partially dissolved when heated. The ratio may be appropriately determined based on the diastereomer excess, the target optical purity after purification, the diastereomer excess, and the recovery rate. Usually, the general formula [1]
The amount of the optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamine may be 1 volume or more, preferably 1 to 100 volumes, more preferably 1 to 50 volumes. Is more preferred.

【0020】本発明の再結晶操作においては、種結晶を
添加することにより、円滑に且つ効率良く結晶を析出さ
せることができる。用いられる種結晶の使用量として
は、精製前の塩に対して、1/10〜1/10000重
量の添加が好ましく、特に、1/20〜1/1000重
量の添加がより好ましい。
In the recrystallization operation of the present invention, crystals can be deposited smoothly and efficiently by adding a seed crystal. The amount of the seed crystal used is preferably 1/10 to 1/10000 weight, more preferably 1/20 to 1/1000 weight, based on the salt before purification.

【0021】本発明の再結晶操作の温度条件は、使用す
る溶媒の沸点および凝固点により適宜決めることがで
き、通常、室温(25℃)から再結晶溶媒の沸点付近の
温度で、精製前の塩を溶解させ、−40〜80℃で結晶
を析出させることができる。
The temperature conditions for the recrystallization operation of the present invention can be appropriately determined depending on the boiling point and the freezing point of the solvent used. Usually, the temperature before room temperature (25 ° C.) is around the boiling point of the recrystallization solvent, Is dissolved, and crystals can be precipitated at -40 to 80 ° C.

【0022】本発明においては、析出した結晶の光学純
度またはジアステレオマー過剰率が向上するため、析出
した結晶を濾過等で回収することにより、高い純度のα
−メチル−ビス−3,5−(トリフルオロメチル)ベン
ジルアミン類の塩を得ることができる。また、再結晶操
作を繰り返すことにより、さらに高い純度のものを得る
ことができる。得られた塩が、1−aの塩の場合には、
水酸化ナトリウム、炭酸水素ナトリウム等のアルカリ性
水溶液で中和し、有機溶媒で抽出することにより、高い
光学純度のα−メチル−ビス−3,5−(トリフルオロ
メチル)ベンジルアミンを回収することができる。
In the present invention, since the optical purity or diastereomer excess of the precipitated crystal is improved, the precipitated crystal is recovered by filtration or the like to obtain a high purity α.
-Methyl-bis-3,5- (trifluoromethyl) benzylamines can be obtained. Further, by repeating the recrystallization operation, a product having a higher purity can be obtained. When the obtained salt is the salt of 1-a,
It is possible to recover α-methyl-bis-3,5- (trifluoromethyl) benzylamine of high optical purity by neutralizing with an aqueous alkaline solution such as sodium hydroxide and sodium hydrogen carbonate, and extracting with an organic solvent. it can.

【0023】また、1−b〜1−fの塩の場合には、塩
のままで、または、アルカリ性水溶液で遊離塩基にした
後で、加水素分解等の脱保護反応により、ラセミ化する
ことなく、目的とする高い光学純度のα−メチル−ビス
−3,5−(トリフルオロメチル)ベンジルアミンを得
ることができる(塩のままで脱保護反応を行った場合に
は、反応終了後、アルカリ性水溶液で中和し、有機溶媒
で抽出することにより、該光学活性アミンを遊離塩基と
して回収することができる。また、得られた該光学活性
アミンの粗生成物は、必要に応じて、活性炭、蒸留、再
結晶、カラムクロマトグラフィー等により、精製するこ
とができる。
In the case of the salts of 1-b to 1-f, racemization is carried out as a salt or after forming a free base with an alkaline aqueous solution, by a deprotection reaction such as hydrogenolysis. Thus, the objective α-methyl-bis-3,5- (trifluoromethyl) benzylamine having a high optical purity can be obtained. The optically active amine can be recovered as a free base by neutralizing with an aqueous alkaline solution and extracting with an organic solvent. , Distillation, recrystallization, column chromatography and the like.

【0024】[0024]

【実施例】 以下、実施例により、本発明の実施の形態
を具体的に説明するが、本発明はこれらの実施例に限定
されるものではない。
EXAMPLES Hereinafter, embodiments of the present invention will be described specifically with reference to Examples, but the present invention is not limited to these Examples.

【0025】実施例に示した光学活性α−メチル−ビス
−3,5−(トリフルオロメチル)ベンジルアミンの絶
対配置は、旋光度の実測値の符号と文献値の符号を比較
して決定した。また、合成中間体の絶対配置は、加水素
分解による脱保護反応を行い、該光学活性アミンに変換
して決定した。実施例および参考例にある%de、%e
eは、それぞれジアステレオマー過剰率、エナンチオマ
ー過剰率を表し、キラルGC(CP−Chirasil
−Dex CB)により決定した。
The absolute configuration of the optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamine shown in the examples was determined by comparing the sign of the measured optical rotation with the sign of the literature value. . Further, the absolute configuration of the synthetic intermediate was determined by performing a deprotection reaction by hydrogenolysis and converting to an optically active amine. % De and% e in Examples and Reference Examples
e represents a diastereomeric excess and an enantiomeric excess, respectively, and represents chiral GC (CP-Chirasil).
-Dex CB).

【0026】[実施例1]/1−aのp−トルエンスル
ホン酸塩による再結晶精製 トルエン6.5mlに、光学活性α−メチル−ビス−
3,5−(トリフルオロメチル)ベンジルアミン(1−
a、エナンチオマー比/S体:R体=7.4:1)1.
02g(3.97mmol、1eq)とp−トルエンス
ルホン酸・一水和物0.68g(3.59mmol、
0.9eq)を加え、60〜70℃で30分間撹拌し、
n−ヘキサン6mlを加え、室温まで放冷後、一日間放
置した。析出した結晶を濾過し,少量のn−ヘキサンで
洗浄し、真空乾燥後、下式に示す構造の結晶0.20g
と母液1.44gを得た。それぞれのeeは、0.5N
−NaOH水溶液で遊離塩基にして、キラルGC分析し
たところ、82.7%ee(メジャー体はS体)、7
4.2%ee(メジャー体はS体)であった。
[Example 1] Recrystallization purification of / 1-a with p-toluenesulfonate In 6.5 ml of toluene, optically active α-methyl-bis- was added.
3,5- (trifluoromethyl) benzylamine (1-
a, enantiomeric ratio / S-form: R-form = 7.4: 1)
02g (3.97 mmol, 1 eq) and 0.68 g (3.59 mmol, p-toluenesulfonic acid monohydrate)
0.9 eq) and stirred at 60-70 ° C. for 30 minutes,
6 ml of n-hexane was added, and the mixture was allowed to cool to room temperature and left for one day. The precipitated crystals were filtered, washed with a small amount of n-hexane, dried in vacuo, and then 0.20 g of crystals having the structure shown below.
And 1.44 g of mother liquor were obtained. Each ee is 0.5N
-The base was converted to a free base with an aqueous solution of NaOH, and chiral GC analysis revealed that 82.7% ee (major form was S form), 7
It was 4.2% ee (the major body was an S body).

【0027】[0027]

【化6】 Embedded image

【0028】1H−NMR(TMS、DMSO):1.
54(d、6.8Hz、3H)、2.28(s、3
H)、4.69(q、6.8Hz、1H)、7.10
(d、8.3Hz、2H)、7.46(d、8.3H
z、2H)、8.17(s、1H)、8.23(s、2
H)、8.30(br、3H)。
1 H-NMR (TMS, DMSO):
54 (d, 6.8 Hz, 3H), 2.28 (s, 3
H), 4.69 (q, 6.8 Hz, 1H), 7.10
(D, 8.3 Hz, 2H), 7.46 (d, 8.3H
z, 2H), 8.17 (s, 1H), 8.23 (s, 2H)
H), 8.30 (br, 3H).

【0029】[実施例2]/1−aの(D)−酒石酸塩
による再結晶精製 メタノール30mlに、光学活性α−メチル−ビス−
3,5−(トリフルオロメチル)ベンジルアミン(1−
a、エナンチオマー比/S体:R体=7.4:1)0.
94g(3.64mmol、1eq)と(D)−酒石酸
0.55g(3.64mmol、1eq)を加え、還流
下30分間撹拌し、室温まで放冷後、半日放置した。析
出した結晶を濾過し、少量のメタノールで洗浄し、真空
乾燥後、下式に示す構造の結晶1.01gと母液0.4
8gを得た。それぞれのeeは、0.5N−NaOH水
溶液で遊離塩基にして、キラルGC分析したところ、そ
れぞれ91.4%ee(メジャー体はS体)、43.8
%ee(メジャー体はS体)であった。
[Example 2] Recrystallization and purification of (1-a) with (D) -tartrate salt 30 ml of methanol was added to optically active α-methyl-bis-
3,5- (trifluoromethyl) benzylamine (1-
a, enantiomeric ratio / S-form: R-form = 7.4: 1)
94 g (3.64 mmol, 1 eq) and 0.55 g (3.64 mmol, 1 eq) of (D) -tartaric acid were added, and the mixture was stirred under reflux for 30 minutes, allowed to cool to room temperature, and left for half a day. The precipitated crystals were collected by filtration, washed with a small amount of methanol, and dried in vacuo.
8 g were obtained. Each ee was converted to a free base with a 0.5N-NaOH aqueous solution and subjected to chiral GC analysis. As a result, 91.4% ee (major form was S form) and 43.8%, respectively.
% Ee (major body is S body).

【0030】[0030]

【化7】 Embedded image

【0031】1H−NMR(TMS、DMSO):1.
45(d、6.8Hz、3H)、3.92(s、2
H)、4.52(q、6.8Hz、1H)、8.08
(s、1H)、8.19(s、2H)。
1 H-NMR (TMS, DMSO):
45 (d, 6.8 Hz, 3H), 3.92 (s, 2
H) 4.52 (q, 6.8 Hz, 1H), 8.08
(S, 1H), 8.19 (s, 2H).

【0032】[実施例3]/1−aの(S)−マンデル
酸塩による再結晶精製 トルエン3mlに、光学活性α−メチル−ビス−3,5
−(トリフルオロメチル)ベンジルアミン(1−a、エ
ナンチオマー比/S体:R体=3.8:1)0.64g
(2.49mmol、1eq)と(S)−マンデル酸
0.17g(1.12mmol、0.45eq)を加
え、還流下30分間撹拌し、n−ヘキサン1.5mlを
加え、室温まで放冷後、冷蔵庫で2日間放置した。析出
した結晶を濾過し、少量のn−ヘキサンで洗浄し、真空
乾燥後、下式に示す構造の結晶0.53gと母液0.2
8gを得た。それぞれのeeは、0.5N−NaOH水
溶液で遊離塩基にして、キラルGC分析したところ、9
6.1%ee(メジャー体はS体)、4.7%ee(メ
ジャー体はS体)であった。
[Example 3] Recrystallization purification of (1 / a) with (S) -mandelic acid salt 3 ml of toluene was added with optically active α-methyl-bis-3,5.
0.64 g of-(trifluoromethyl) benzylamine (1-a, enantiomeric ratio / S-form: R-form = 3.8: 1)
(2.49 mmol, 1 eq) and 0.17 g (1.12 mmol, 0.45 eq) of (S) -mandelic acid were added, and the mixture was stirred under reflux for 30 minutes, added with 1.5 ml of n-hexane, and allowed to cool to room temperature. And left in the refrigerator for 2 days. The precipitated crystals were collected by filtration, washed with a small amount of n-hexane, and dried under vacuum.
8 g were obtained. Each ee was converted to a free base with a 0.5N-NaOH aqueous solution and subjected to chiral GC analysis.
6.1% ee (major body was S body) and 4.7% ee (major body was S body).

【0033】[0033]

【化8】 Embedded image

【0034】1H−NMR(TMS、DMSO):1.
39(d、6.8Hz、3H)、4.41(q、6.8
Hz、1H)、4.71(d、2.0Hz、1H)、
7.19(t、7.3Hz、1H)、7.26(t、
7.3Hz、2H)、7.36(d、7.3Hz、2
H)、8.01(s、1H)、8.15(s、2H)。
1 H-NMR (TMS, DMSO):
39 (d, 6.8 Hz, 3H), 4.41 (q, 6.8
Hz, 1H), 4.71 (d, 2.0 Hz, 1H),
7.19 (t, 7.3 Hz, 1H), 7.26 (t,
7.3 Hz, 2H), 7.36 (d, 7.3 Hz, 2
H), 8.01 (s, 1H), 8.15 (s, 2H).

【0035】[実施例4]/1−aの(S)−マンデル
酸塩による再結晶精製 トルエン4.5mlに、光学活性α−メチル−ビス−
3,5−(トリフルオロメチル)ベンジルアミン(1−
a、エナンチオマー比/S体:R体=8.8:1)0.
80g(3.10mmol、1eq)と(S)−マンデ
ル酸0.47g(3.09mmol、1eq)を加え、
還流下30分間撹拌し、n−ヘキサン1.8mlを加
え、室温まで放冷後、種結晶を加え、3時間放置した。
析出した結晶を濾過し、少量のn−ヘキサンで洗浄し、
真空乾燥後、下式に示す構造の結晶0.89gと母液
0.35gを得た。それぞれのeeは、0.5N−Na
OH水溶液で遊離塩基にして、キラルGC分析したとこ
ろ、90.7%ee(メジャー体はS体)、58.1%
ee(メジャー体はS体)であった。
[Example 4] Purification of recrystallization of (1 / a) with (S) -mandelic acid salt In 4.5 ml of toluene, optically active α-methyl-bis- was added.
3,5- (trifluoromethyl) benzylamine (1-
a, enantiomeric ratio / S-form: R-form = 8.8: 1)
80 g (3.10 mmol, 1 eq) and 0.47 g (3.09 mmol, 1 eq) of (S) -mandelic acid were added,
The mixture was stirred under reflux for 30 minutes, 1.8 ml of n-hexane was added, and after allowing to cool to room temperature, seed crystals were added and the mixture was allowed to stand for 3 hours.
The precipitated crystals are filtered and washed with a small amount of n-hexane,
After vacuum drying, 0.89 g of crystals having the structure shown below and 0.35 g of mother liquor were obtained. Each ee is 0.5N-Na
It was made into a free base with an aqueous OH solution and subjected to chiral GC analysis. As a result, 90.7% ee (major form was S form), 58.1%
ee (major body is S body).

【0036】[0036]

【化9】 Embedded image

【0037】1H−NMRスペクトルは実施例3と同じ
ものを示した。
The 1 H-NMR spectrum was the same as in Example 3.

【0038】[実施例5]/1−aの(S)−マンデル
酸塩による再結晶精製 トルエン10mlに、光学活性α−メチル−ビス−3,
5−(トリフルオロメチル)ベンジルアミンの(S)−
マンデル酸塩(1−a・(S)−マンデル酸塩、エナン
チオマー比/S体:R体=95.5:4.5)0.89
gを加え、80℃で30分間撹拌し、室温まで放冷後、
1時間放置した。析出した結晶を濾過し,少量のトルエ
ンで洗浄し、真空乾燥後、下式に示す構造の結晶0.7
1gと母液0.18gを得た。それぞれのeeは、0.
5N−NaOH水溶液で遊離塩基にして、キラルGC分
析したところ、99.7%ee(メジャー体はS体)、
82.7%ee(メジャー体はS体)であった。
Example 5 Purification of recrystallization of (1-a) with (S) -mandelic acid salt To 10 ml of toluene was added optically active α-methyl-bis-3,
(S)-of 5- (trifluoromethyl) benzylamine
Mandelate (1-a · (S) -mandelate, enantiomeric ratio / S-form: R-form = 95.5: 4.5) 0.89
g, stirred at 80 ° C. for 30 minutes, and allowed to cool to room temperature.
Left for 1 hour. The precipitated crystals were collected by filtration, washed with a small amount of toluene, and dried in vacuo.
1 g and 0.18 g of mother liquor were obtained. Each ee is 0.
As a result of chiral GC analysis after making a free base with a 5N-NaOH aqueous solution, 99.7% ee (major form is S form),
It was 82.7% ee (the major body was an S body).

【0039】[0039]

【化10】 Embedded image

【0040】1H−NMRスペクトルは実施例3と同じ
ものを示した。
The 1 H-NMR spectrum was the same as in Example 3.

【0041】[実施例6]/1−dの塩酸塩による再結
晶精製 メタノール20mlに、光学活性α−メチル−ビス−
3,5−(トリフルオロメチル)ベンジルアミン類(1
−d、ジアステレオマー比/S−S体:R−S体=7.
5:1)2.32g(6.43mmol)を溶解し、氷
冷下、10%塩酸メタノールを過剰量加え、同温度で3
0分間撹拌し、濃縮、真空乾燥後、1−dの塩酸塩の粗
生成物を定量的収率で得た。粗生成物に、n−ヘキサン
−エタノールの混合溶液(50:1)30mlを加え、
50℃で30分間撹拌洗浄し、室温まで放冷後、一晩放
置した。析出した結晶を濾過し、少量のn−ヘキサンで
洗浄し、真空乾燥後、下式に示す構造の結晶1.98g
と母液0.58gを得た。それぞれのdeは、0.5N
−NaOH水溶液で遊離塩基にして、キラルGC分析し
たところ、それぞれ82.4%de(メジャー体はS−
S体)、54.7%de(メジャー体はS−S体)であ
った。
[Example 6] Purification of recrystallization with hydrochloride salt of / 1-d Optically active α-methyl-bis-
3,5- (trifluoromethyl) benzylamines (1
-D, diastereomer ratio / SS form: RS form = 7.
5: 1) 2.32 g (6.43 mmol) was dissolved, and 10% hydrochloric acid methanol was added in excess under ice-cooling.
After stirring for 0 minutes, concentration and drying in vacuo, a crude product of the hydrochloride salt of 1-d was obtained in a quantitative yield. 30 ml of a mixed solution (50: 1) of n-hexane-ethanol was added to the crude product,
The mixture was stirred and washed at 50 ° C. for 30 minutes, allowed to cool to room temperature, and left overnight. The precipitated crystals were filtered, washed with a small amount of n-hexane, dried in vacuo, and then 1.98 g of crystals having the structure shown below.
And 0.58 g of mother liquor. Each de is 0.5N
-The base was converted to a free base with an aqueous solution of NaOH and analyzed by chiral GC.
(S-form), 54.7% de (major form is S-S form).

【0042】[0042]

【化11】 Embedded image

【0043】1H−NMR(TMS、DMSO):1.
58(d、6.8Hz、3H)、1.62(d、6.8
Hz、3H)、3.99(q、6.8Hz、1H)、
4.28(q、6.8Hz、1H)、7.25−7.4
8(m、5H)、8.13(s、3H)、10.22
(br、1H)、10.53(br、1H)。
1 H-NMR (TMS, DMSO):
58 (d, 6.8 Hz, 3H), 1.62 (d, 6.8
Hz, 3H), 3.99 (q, 6.8 Hz, 1H),
4.28 (q, 6.8 Hz, 1H), 7.25-7.4
8 (m, 5H), 8.13 (s, 3H), 10.22
(Br, 1H), 10.53 (br, 1H).

【0044】[実施例7]/1−dのp−トルエンスル
ホン酸塩による再結晶精製 t−ブチルメチルエーテル42mlに、光学活性α−メ
チル−ビス−3,5−(トリフルオロメチル)ベンジル
アミン類(1−d、ジアステレオマー比/S−S体:R
−S体=7.5:1)3.04g(8.42mmol、
1eq)とp−トルエンスルホン酸・一水和物1.60
g(8.42mmol、1eq)を加え、60℃で40
分間撹拌し、n−ヘキサン72mlを加え、室温まで放
冷後、種結晶を加え、一晩放置した。析出した結晶を濾
過し、少量のn−ヘキサンで洗浄し、真空乾燥後、下式
に示す構造の結晶3.12gと母液1.37gを得た。
それぞれのdeは、0.5N−NaOH水溶液で遊離塩
基にして、キラルGC分析したところ、それぞれ99.
3%de(メジャー体はS−S体)、16.6%de
(メジャー体はS−S体)であった。
Example 7 Purification of recrystallization of p-toluenesulfonic acid salt of / 1-d in 42 ml of t-butyl methyl ether was added an optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamine (1-d, diastereomer ratio / SS form: R)
-S form = 7.5: 1) 3.04 g (8.42 mmol,
1eq) and p-toluenesulfonic acid monohydrate 1.60
g (8.42 mmol, 1 eq) at 40.degree.
After stirring for 72 minutes, 72 ml of n-hexane was added, and after allowing to cool to room temperature, seed crystals were added and left overnight. The precipitated crystals were filtered, washed with a small amount of n-hexane, and dried under vacuum to obtain 3.12 g of crystals having the structure shown below and 1.37 g of mother liquor.
Each de was converted to a free base with a 0.5N-NaOH aqueous solution and subjected to chiral GC analysis.
3% de (major body is SS body), 16.6% de
(The major body was an SS body).

【0045】[0045]

【化12】 Embedded image

【0046】1H−NMR(TMS、DMSO):1.
55(d、6.0Hz、3H)、1.58(d、6.0
Hz、3H)、2.28(s、3H)、4.29(q、
6.0Hz、1H)、4.54(q、6.0Hz、1
H)、7.11(d、8.0Hz、2H)、7.38
(m、2H)、7.43(m、3H)、7.47(d、
8.0Hz、2H)、8.10(s、2H)、8.20
(s、1H)、9.41(br、2H)。
1 H-NMR (TMS, DMSO):
55 (d, 6.0 Hz, 3H), 1.58 (d, 6.0
Hz, 3H), 2.28 (s, 3H), 4.29 (q,
6.0 Hz, 1H), 4.54 (q, 6.0 Hz, 1H)
H), 7.11 (d, 8.0 Hz, 2H), 7.38
(M, 2H), 7.43 (m, 3H), 7.47 (d,
8.0 Hz, 2H), 8.10 (s, 2H), 8.20
(S, 1H), 9.41 (br, 2H).

【0047】[実施例8]/1−dの(S)−マンデル
酸塩による再結晶精製 トルエン1mlに、光学活性α−メチル−ビス−3,5
−(トリフルオロメチル)ベンジルアミン類(1−d、
ジアステレオマー比/S−S体:R−S体=7:1)
0.81g(2.23mmol、1eq)と(S)−マ
ンデル酸0.34g(2.23mmol、1eq)を加
え、60℃で30分間撹拌し、n−ヘキサン6mlを加
え、室温まで放冷後、一晩放置した。析出した結晶を濾
過し、少量のn−ヘキサンで洗浄し、真空乾燥後、下式
に示す構造の結晶0.99gと母液0.12gを得た。
それぞれのdeは、0.5N−NaOH水溶液で遊離塩
基にして、キラルGC分析したところ、それぞれ77.
2%de(メジャー体はS−S体)、57.8%de
(メジャー体はS−S体)であった。
[Example 8] Purification of recrystallization of (1-d) with (S) -mandelic acid salt. To 1 ml of toluene, optically active α-methyl-bis-3,5 was added.
-(Trifluoromethyl) benzylamines (1-d,
Diastereomer ratio / SS form: RS form = 7: 1)
0.81 g (2.23 mmol, 1 eq) and (S) -mandelic acid 0.34 g (2.23 mmol, 1 eq) were added, and the mixture was stirred at 60 ° C. for 30 minutes, added with n-hexane 6 ml, and allowed to cool to room temperature. , Left overnight. The precipitated crystals were filtered, washed with a small amount of n-hexane, and dried under vacuum to obtain 0.99 g of crystals having the structure shown below and 0.12 g of mother liquor.
Each de was converted to a free base with a 0.5N-NaOH aqueous solution and subjected to chiral GC analysis.
2% de (major body is SS body), 57.8% de
(The major body was an SS body).

【0048】[0048]

【化13】 Embedded image

【0049】1H−NMR(TMS、DMSO):1.
19(d、6.4Hz、3H)、1.23(d、6.4
Hz、3H)、3.29(q、6.4Hz、1H)、
3.60(q、6.4Hz、1H)、4.99(s、1
H)、7.07−7.46(m、10H)、7.92
(s、2H)、7.94(s、1H)。
1 H-NMR (TMS, DMSO):
19 (d, 6.4 Hz, 3H), 1.23 (d, 6.4
Hz, 3H), 3.29 (q, 6.4 Hz, 1H),
3.60 (q, 6.4 Hz, 1H), 4.99 (s, 1
H), 7.07-7.46 (m, 10H), 7.92
(S, 2H), 7.94 (s, 1H).

【0050】[参考例1]/精製した1−d・p−トル
エンスルホン酸塩の光学活性α−メチル−ビス−3,5
−(トリフルオロメチル)ベンジルアミンへの変換 トルエン50mlに、実施例7を参考にして精製した光
学活性α−メチル−ビス−3,5−(トリフルオロメチ
ル)ベンジルアミン類のp−トルエンスルホン酸塩(1
−d・p−トルエンスルホン酸塩、99.6%de、メ
ジャー体はS−S体)13.3g(24.95mmo
l、1eq)と0.5N−NaOH水溶液100ml
(50mmol、2eq)を加え、室温で30分間撹拌
し、静定分液後、回収水層をトルエンで抽出し、合わせ
た回収有機層を飽和食塩水で洗浄し、無水硫酸ナトリウ
ムで乾燥し、濾過、濃縮、真空乾燥後、下式に示す構造
の1−dを定量的収率で得た。
Reference Example 1 Optically active α-methyl-bis-3,5 of purified 1-dp-toluenesulfonic acid salt
Conversion to-(trifluoromethyl) benzylamine In 50 ml of toluene, p-toluenesulfonic acid of optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamine purified with reference to Example 7 Salt (1
-D.p-toluenesulfonate, 99.6% de, major form is SS form) 13.3 g (24.95 mmo)
1, 1 eq) and 100 ml of 0.5N-NaOH aqueous solution
(50 mmol, 2 eq), and the mixture was stirred at room temperature for 30 minutes. After static separation, the recovered aqueous layer was extracted with toluene, and the combined recovered organic layers were washed with saturated saline and dried over anhydrous sodium sulfate. After filtration, concentration and vacuum drying, 1-d having the structure shown below was obtained in a quantitative yield.

【0051】[0051]

【化14】 Embedded image

【0052】得られた1−dをメタノール26mlに溶
解し、5%パラジウム/活性炭(50重量%含水)0.
45g(5重量%)を加え、水素圧を0.2MPaに設
定し、60℃で22時間撹拌した。反応終了液をセライ
ト濾過し、濃縮、真空乾燥後、下式に示す構造の(S)
−1−aの粗生成物を定量的収率で得た。粗生成物は、
単蒸留による精製(96−97℃/31mmHg)を行
い、高純度品5.41gを得た(2ステップのトータル
収率は84%)。GC純度およびeeは、それぞれ9
9.4%、99.4%eeであった。
The obtained 1-d was dissolved in 26 ml of methanol, and 5% palladium / activated carbon (containing 50% by weight of water) was added.
45 g (5% by weight) was added, the hydrogen pressure was set to 0.2 MPa, and the mixture was stirred at 60 ° C for 22 hours. The reaction-terminated liquid is filtered through celite, concentrated, and dried under vacuum.
The crude product of -1-a was obtained in a quantitative yield. The crude product is
Purification by simple distillation (96-97 ° C / 31 mmHg) was performed to obtain 5.41 g of a high-purity product (total yield of two steps is 84%). GC purity and ee were 9
9.4% and 99.4% ee.

【0053】[0053]

【化15】 Embedded image

【0054】[0054]

【発明の効果】医薬および農薬の重要中間体である光学
活性α−メチル−ビス−3,5−(トリフルオロメチ
ル)ベンジルアミンを工業的に簡便で且つ効率良く高い
光学純度に精製できる。
Industrial Applicability The optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamine, which is an important intermediate of pharmaceuticals and agricultural chemicals, can be industrially simply and efficiently purified to high optical purity.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 安本 学 埼玉県川越市今福中台2805番地 セントラ ル硝子株式会社化学研究所内 (72)発明者 金井 正富 埼玉県川越市今福中台2805番地 セントラ ル硝子株式会社化学研究所内 (72)発明者 速水 崇 埼玉県川越市今福中台2805番地 セントラ ル硝子株式会社化学研究所内 Fターム(参考) 4H006 AA02 AC83 AD15 AD33 BB11 BB14 BB15 BC10 BC19 BC51 ──────────────────────────────────────────────────続 き Continued on the front page (72) Inventor Manabu Yasumoto 2805 Imafukunakadai, Kawagoe-shi, Saitama Prefecture Central Research Institute of Glass Co., Ltd. (72) Inventor Masatomi Kanai 2805 Imafukunakadai, Kawagoe-shi, Saitama Central Inside Glass Chemical Company (72) Inventor Takashi Hayami 2805 Imafukunakadai, Kawagoe City, Saitama Prefecture Central Glass Company Chemical Laboratory F-term (reference) 4H006 AA02 AC83 AD15 AD33 BB11 BB14 BB15 BC10 BC19 BC51

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】 一般式[1] 【化1】 [式中、Rは、水素、ベンジル基、アリル基またはC*
HMeArで示される光学活性α−アリールエチル基を
表し、Arは、フェニル基または1もしくは2−ナフチ
ル基を表し、*は、不斉炭素を表す]で示される光学活
性α−メチル−ビス−3,5−(トリフルオロメチル)
ベンジルアミン類を無機酸または有機酸の塩にして再結
晶精製することを特徴とする精製方法。
1. A compound of the general formula [1] Wherein R is hydrogen, benzyl, allyl or C *
Represents an optically active α-arylethyl group represented by HMeAr, Ar represents a phenyl group or 1 or 2-naphthyl group, and * represents an asymmetric carbon]. , 5- (trifluoromethyl)
A refining method comprising converting a benzylamine into a salt of an inorganic acid or an organic acid and recrystallizing the same.
【請求項2】 無機酸が、塩酸である請求項1に記載し
た精製方法。
2. The purification method according to claim 1, wherein the inorganic acid is hydrochloric acid.
【請求項3】 有機酸が、p−トルエンスルホン酸、光
学活性酒石酸、光学活性マンデル酸よりなる群から選ば
れる請求項1に記載した精製方法。
3. The method according to claim 1, wherein the organic acid is selected from the group consisting of p-toluenesulfonic acid, optically active tartaric acid, and optically active mandelic acid.
【請求項4】 一般式[1]の*の立体化学が、R体ま
たはS体である請求項1乃至請求項3のいずれかに記載
した精製方法。
4. The purification method according to claim 1, wherein the stereochemistry of * in the general formula [1] is R-form or S-form.
【請求項5】 一般式[1] 【化2】 [式中、Rは、水素、ベンジル基、アリル基またはC*
HMeArで示される光学活性α−アリールエチル基を
表し、Arは、フェニル基または1もしくは2−ナフチ
ル基を表し、*は、不斉炭素を表す]で示される光学活
性α−メチル−ビス−3,5−(トリフルオロメチル)
ベンジルアミン類の無機酸または有機酸の塩。
5. A compound of the general formula [1] Wherein R is hydrogen, benzyl, allyl or C *
Represents an optically active α-arylethyl group represented by HMeAr, Ar represents a phenyl group or 1 or 2-naphthyl group, and * represents an asymmetric carbon]. , 5- (trifluoromethyl)
Salts of benzylamines with inorganic or organic acids.
【請求項6】 無機酸が、塩酸である請求項5に記載し
た塩。
6. The salt according to claim 5, wherein the inorganic acid is hydrochloric acid.
【請求項7】 有機酸が、p−トルエンスルホン酸、光
学活性酒石酸、光学活性マンデル酸よりなる群から選ば
れる請求項5に記載した塩。
7. The salt according to claim 5, wherein the organic acid is selected from the group consisting of p-toluenesulfonic acid, optically active tartaric acid, and optically active mandelic acid.
【請求項8】 一般式[1]の*の立体化学が、R体ま
たはS体である請求項5乃至請求項7のいずれかに記載
した塩。
8. The salt according to claim 5, wherein the stereochemistry of * in the general formula [1] is R-form or S-form.
JP2000185405A 2000-05-11 2000-06-20 Method for purifying optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamines Expired - Fee Related JP3902384B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2000185405A JP3902384B2 (en) 2000-06-20 2000-06-20 Method for purifying optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamines
US09/853,085 US6797842B2 (en) 2000-05-11 2001-05-11 Process for producing optically active 1-(fluoro- or trifluoromethyl-substituted phenyl) ethylamine and process for purifying same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000185405A JP3902384B2 (en) 2000-06-20 2000-06-20 Method for purifying optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamines

Publications (2)

Publication Number Publication Date
JP2002003453A true JP2002003453A (en) 2002-01-09
JP3902384B2 JP3902384B2 (en) 2007-04-04

Family

ID=18685729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000185405A Expired - Fee Related JP3902384B2 (en) 2000-05-11 2000-06-20 Method for purifying optically active α-methyl-bis-3,5- (trifluoromethyl) benzylamines

Country Status (1)

Country Link
JP (1) JP3902384B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081551B2 (en) 2002-05-21 2006-07-25 Central Glass Co., Ltd. Optically active (R)-1-(4-trifluoromethylphenyl)ethylamine
WO2008001719A1 (en) * 2006-06-30 2008-01-03 Central Glass Company, Limited Method for producing optically active 1-(fluoro-, trifluoromethyl- or trifluoromethoxy-substituted phenyl)alkylamine n-monoalkyl derivative
JP2011231071A (en) * 2010-04-28 2011-11-17 Central Glass Co Ltd Optical resolution which obtains optical activity (r)-1-(4-fluoro phenyl)ethylamine
CN103896009A (en) * 2014-03-07 2014-07-02 浙江瀚镪自动化设备股份有限公司 Belt conveyor with slope section and horizontal section connected with each other

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081551B2 (en) 2002-05-21 2006-07-25 Central Glass Co., Ltd. Optically active (R)-1-(4-trifluoromethylphenyl)ethylamine
WO2008001719A1 (en) * 2006-06-30 2008-01-03 Central Glass Company, Limited Method for producing optically active 1-(fluoro-, trifluoromethyl- or trifluoromethoxy-substituted phenyl)alkylamine n-monoalkyl derivative
JP2008007489A (en) * 2006-06-30 2008-01-17 Central Glass Co Ltd Method for manufacturing optically active 1-(fluoro, trifluoromethyl or trifluoromethoxy-substituted phenyl)alkylamine n-monoalkyl derivative
US7985880B2 (en) 2006-06-30 2011-07-26 Central Glass Company, Limited Method for producing optically active 1-(fluoro-, trifluoromethyl- or trifluoromethoxy-substituted phenyl) alkylamine N-monoalkyl derivative
JP2011231071A (en) * 2010-04-28 2011-11-17 Central Glass Co Ltd Optical resolution which obtains optical activity (r)-1-(4-fluoro phenyl)ethylamine
CN103896009A (en) * 2014-03-07 2014-07-02 浙江瀚镪自动化设备股份有限公司 Belt conveyor with slope section and horizontal section connected with each other

Also Published As

Publication number Publication date
JP3902384B2 (en) 2007-04-04

Similar Documents

Publication Publication Date Title
JP5202519B2 (en) (R)-(−)-3- (Carbamoylmethyl) -5-methylhexanoic acid, pregabalin, and synthetic intermediate production method
JP4170990B2 (en) Process for producing optically active serine derivatives
WO2008117305A2 (en) A novel process for preparing pregabalin and its acid addition salts
US8420846B2 (en) Process for producing (S)-3-[(1-dimethylamino)ethyl] phenyl-N-ethyl-N-methyl-carbamate via novel intermediates
WO2002068376A1 (en) Process for the preparation of rasagiline and its salts
JP2002003453A (en) METHOD FOR PURIFYING OPTICALLY ACTIVE alpha-METHYL- BIS-3,5-(TRIFLUOROMETHYL) BENZYLAMINES
JP4079727B2 (en) Optically active 1- (fluoro, trifluoromethyl or trifluoromethoxy substituted phenyl) alkylamine N-monoalkyl derivatives and process for producing the same
JP3982993B2 (en) Method for purifying optically active 1- (trifluoromethylmono-substituted phenyl) ethylamine
US7459586B2 (en) Optically active 1-aryl-2-fluoro-substituted ethylamine and method for producing same
JP4287703B2 (en) Process for producing optically active 1-alkyl-substituted-2,2,2-trifluoroethylamine
US6797842B2 (en) Process for producing optically active 1-(fluoro- or trifluoromethyl-substituted phenyl) ethylamine and process for purifying same
JP4904945B2 (en) Process for producing optically active 1- (fluoro, trifluoromethyl or trifluoromethoxy substituted phenyl) alkylamine N-monoalkyl derivatives
JP4049548B2 (en) Method for purifying optically active 1- (fluorophenyl) ethylamine
JP2010513531A (en) Process for the preparation and isolation of individual stereoisomers of 1-amino, 3-substituted phenylcyclopentanecarboxylic esters
JP2009507783A (en) Process for producing chiral 3-hydroxypyrrolidine compound having high optical purity and derivative thereof
JP2010513531A5 (en)
US20230391715A1 (en) Novel process for preparing solriamfetol hydrochloride
JP4437648B2 (en) Process for producing optically active 1- (2-trifluoromethylphenyl) ethylamine
JP5510040B2 (en) Optical resolution to obtain optically active (R) -1- (4-fluorophenyl) ethylamine
JP2002371060A (en) Method for producing optically active aminopiperidine derivative
WO2002085833A1 (en) Processes for preparation of optically active 2-benzyl- succinic acid and optically active 2-benzylsuccinic acid monoamides
JP2007277224A (en) Method for producing trans-4-amino-1-methylcyclohexanols
CA2543606A1 (en) Resolution of 3-amino alkylnitriles
WO2003068727A1 (en) PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE β-PHENYLALANINE DERIVATIVES
JP2006528167A (en) Preparation of imine intermediate

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20060414

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7421

Effective date: 20060421

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060711

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060907

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20061226

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20061228

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100112

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100112

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110112

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110112

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120112

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120112

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120112

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130112

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130112

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130112

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140112

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees